Phase 1 study assessing the pharmacokinetics of NEX-22A in subjects with T2D

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508054-25-01

Acronym

NEX-22-01

Enrollment

Registered

2024-05-15

Start date

2025-02-26

Completion date

2025-05-05

Last updated

2025-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026